法国医疗科技领域的创新者AZmed近日宣布，成功完成了1500万欧元的A轮融资，投资阵容豪华，包括Maison Worms、Techstars和Tempact Ventures等知名机构。这家初创公司致力于利用人工智能技术改变医学成像的格局，其研发的AI软件Rayvolve引起了业界广泛关注。
Rayvolve是一款革命性的诊断辅助工具，它能够帮助放射科医生和急诊医生快速准确地识别标准放射照相中的各种异常，从而提高诊断效率，减轻医生的工作压力。这款软件的引入，有望显著降低因人为因素导致的诊断错误风险，为患者提供更安全、更及时的医疗服务。
AZmed的这一轮融资，不仅彰显了投资者对AI在医疗领域应用的看好，也标志着该公司在推动医疗科技发展道路上迈出了坚实的一步。借助这笔资金，AZmed计划加速Rayvolve的市场推广，并进一步研发创新技术，以期在未来的医疗保健领域扮演更重要的角色。
来源：Tech.eu
英语如下：
News Title: “AI Medical Miracle! AZmed Secures €15M, Rayvolve Advances Precision Diagnosis”
Keywords: AI Medical Imaging, AZmed Funding, Rayvolve Software
News Content: Title: AI Medical Imaging Trailblazer AZmed Raises €15M in Series A, Pioneering a New Era in Smart Diagnostics
French healthcare tech innovator AZmed recently announced a successful €15 million Series A funding round, backed by prominent investors such as Maison Worms, Techstars, and Tempact Ventures. The startup aims to transform the medical imaging landscape with its AI-powered technology.
Rayvolve, their groundbreaking diagnostic support tool, assists radiologists and emergency physicians in swiftly and accurately identifying abnormalities on standard radiographs, enhancing diagnostic speed and reducing doctors’ workload. The software’s implementation promises to significantly reduce the risk of misdiagnosis due to human factors, ensuring safer and timelier care for patients.
This funding round not only underscores investors’ confidence in AI applications in healthcare but also signals a significant stride for AZmed in advancing medical technology. With the newly acquired capital, the company intends to accelerate Rayvolve’s market penetration and continue developing innovative technologies, positioning itself for a more prominent role in future healthcare.
Source: Tech.eu
【来源】https://tech.eu/2024/02/20/french-medtech-azmed-raises-eur15m/
Views: 1